Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 04/23/2013 - 04/23/2016

This course is closed. Please look for other available products in CPNP University.

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Huntington's Disease (HD) is a progressive neurological disorder, first described by George Huntington in 1872, characterized by chorea, as well as cognitive and behavioral dysfunction.  The United States incident rates of HD are approximately 4 to 7 out of 100,000. HD is inherited in an autosomal dominant pattern, and genetic confirmation is done by examining the number of CAG repeats on chromosome 4. The diagnosis of HD can also be clinical. Although there is no cure for HD, current therapies are generally directed against chorea and psychiatric manifestation of the disease. Current therapies to treat chorea involve both dopamine depleting agents and dopamine antagonists. Pharmacotherapy for the psychiatric manifestations of HD is often individualized since clinical presentation will vary from patient to patient.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Discuss the genetic causation of Huntington’s disease
  2. Recognize the natural course of disease in a patient with Huntington’s disease
  3. Assess the clinical trials of agents approved to treat movement disorders associated with Huntington’s disease
  4. Develop a treatment plan assessing and treating various neuropsychiatric complications associated with Huntington’s disease.

Continuing Education Credit and Disclosures

Activity Dates: 04/23/2013 - 04/23/2016
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-13-018-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.01 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-000-13-018-L01-P (1.0 contact hours).

ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:

  1. Continuing nursing education (CNE) approved for nursing contact hours by an accredited provider or approver of nursing continuing education
  2. Continuing medical education (CME) approved for CME hours
  3. Sponsored by organizations, agencies, or educational institutions accredited or approved by the American Nurses Credentialing Center (ANCC) or the Accreditation Council for Continuing Medical Education (ACCME) or the Accreditation Council for Pharmacy Education (ACPE) or the Commission on Dietetic Registration

Grant Support

Annual Meeting Grant Provider

Cyberonics